NMC
CADX

NEA Management Company’s CADENCE PHARMACEUTICALS, INC COM STK CADX Stock Holding History

NEA Management Company’s Portfolio CADX Stock Details CADX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-2,070,286
Closed -$18.7M – 31
2013
Q4 		$18.7M Hold
2,070,286
– – 0.91% 19
2013
Q3 		$13M Hold
2,070,286
– – 0.52% 23
2013
Q2 		$14.1M Buy
+2,070,286
New +$14.4M 0.63% 18

Other funds holding CADX

OP
Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

NEA Management Company's CADX Position: Q1 2014 in Review

NEA Management Company sold out of CADENCE PHARMACEUTICALS, INC COM STK (CADX) in Q1 2014, closing a stake of 2,070,286 shares — an estimated $18.7M sold.

NEA Management Company first reported a position in CADX in Q2 2013 and held it in 3 quarters. The position peaked at $18.7M in Q4 2013. 3 funds tracked by Wall St. Rank hold CADX as of Q1 2014.

  • NEA Management Company reported no remaining CADENCE PHARMACEUTICALS, INC COM STK position as of Q1 2014 after selling out during the quarter.
  • NEA Management Company sold 2,070,286 CADENCE PHARMACEUTICALS, INC COM STK shares in Q1 2014, an estimated $18.7M.
  • NEA Management Company first reported a position in CADENCE PHARMACEUTICALS, INC COM STK in Q2 2013 and held it in 3 quarters.
  • NEA Management Company's CADENCE PHARMACEUTICALS, INC COM STK position peaked at $18.7M in Q4 2013.
  • 3 funds tracked by Wall St. Rank held CADENCE PHARMACEUTICALS, INC COM STK as of Q1 2014.

Based on NEA Management Company's 13F filing for Q1 2014, filed 1 May 2014.